-
Science & technology
Science & technology
Novavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.
- Overview
- Our pipeline
- Matrix-M™ adjuvant
- Recombinant, protein-based nanoparticle vaccine
- Global vaccine approval/authorization map
COVID-19 UPDATESNovavax has demonstrated its ability to quickly produce viable vaccine candidates for emerging infectious diseases such as COVID-19.
-
Who we are
Who we are
We are a biotechnology company committed to help address serious infectious disease globally through the discovery, development, and delivery of innovative vaccines to patients around the world.
Build your future with usJoin other passionately curious people who are bringing innovative vaccines to the world
-
Insights
Insights
Novavax is committed to accelerating the development of new and promising vaccines by building on years of study and experience.
Leadership
Our team is composed of experts with an unparalleled knowledge of science, technology, and medicine. Their depth of experience is unmatched in the quest to reduce the burden of infectious disease around the globe.





John A. Herrmann III
Executive Vice President,
Chief Legal Officer,
Business Development,
Strategic Alliances,
Compliance and Corporate Secretary
Chief Legal Officer,
Business Development,
Strategic Alliances,
Compliance and Corporate Secretary




John J. Trizzino
Executive Vice President,
Chief Commercial Officer and Chief Business Officer
Chief Commercial Officer and Chief Business Officer

Henrietta Ukwu, MD
Executive Vice President,
Chief Regulatory Officer
Chief Regulatory Officer

Russell P. "Rip" Wilson
Executive Vice President
and General Manager, Influenza
and General Manager, Influenza


Marco Cacciuttolo
Senior Vice President,
Process and Analytical Development
Process and Analytical Development



Michael Kahsai, PhD
Senior Vice President,
Quality Assurance and Quality Control
Quality Assurance and Quality Control





Brian Rosen
Senior Vice President,
Government Affairs,
Market Access and Alliances
Government Affairs,
Market Access and Alliances

Gale E. Smith, PhD
Senior Vice President,
Discovery and Pre-clinical Research, Chief Scientist
Discovery and Pre-clinical Research, Chief Scientist











